医学
肝移植
肝硬化
肥胖
非酒精性脂肪性肝炎
肌萎缩
肥胖管理
重症监护医学
内科学
减肥
移植
胃肠病学
外科
非酒精性脂肪肝
脂肪肝
疾病
标识
DOI:10.1016/j.cld.2020.08.001
摘要
Obesity is increasing in prevalence in liver transplant candidates and recipients. The rise in liver transplantation for nonalcoholic steatohepatitis reflects this increase. Management of obesity in liver transplant candidates can be challenging due to the presence of decompensated cirrhosis and sarcopenia. Obesity may increase peritransplant morbidity but does not have an impact on long-term post-transplant survival. Bariatric surgery may be a feasible option in select patients before, during, or after liver transplantation. Use of weight loss drugs and/or endoscopic therapies for obesity management ultimately may play a role in liver transplant patients, but more research is needed to determine safety.
科研通智能强力驱动
Strongly Powered by AbleSci AI